152 related articles for article (PubMed ID: 38434525)
21. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
Ailles LE; Humphries RK; Thomas TE; Hogge DE
Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
[TBL] [Abstract][Full Text] [Related]
22. An Improved Protocol for Establishment of AML Patient-Derived Xenograft Models.
Hassan N; Yang J; Wang JY
STAR Protoc; 2020 Dec; 1(3):100156. PubMed ID: 33377050
[TBL] [Abstract][Full Text] [Related]
23. Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells.
You R; Wang B; Chen P; Zheng X; Hou D; Wang X; Zhang B; Chen L; Li D; Lin X; Huang H
Cancer Lett; 2022 Apr; 532():215582. PubMed ID: 35122876
[TBL] [Abstract][Full Text] [Related]
24. Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System.
Rotiroti MC; Buracchi C; Arcangeli S; Galimberti S; Valsecchi MG; Perriello VM; Rasko T; Alberti G; Magnani CF; Cappuzzello C; Lundberg F; Pande A; Dastoli G; Introna M; Serafini M; Biagi E; Izsvák Z; Biondi A; Tettamanti S
Mol Ther; 2020 Sep; 28(9):1974-1986. PubMed ID: 32526203
[TBL] [Abstract][Full Text] [Related]
25. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.
Terpstra W; Rozemuller H; Breems DA; Rombouts EJ; Prins A; FitzGerald DJ; Kreitman RJ; Wielenga JJ; Ploemacher RE; Löwenberg B; Hagenbeek A; Martens AC
Blood; 1997 Nov; 90(9):3735-42. PubMed ID: 9345060
[TBL] [Abstract][Full Text] [Related]
26. A new mouse avatar model of non-small cell lung cancer.
Russo MV; Faversani A; Gatti S; Ricca D; Del Gobbo A; Ferrero S; Palleschi A; Vaira V; Bosari S
Front Oncol; 2015; 5():52. PubMed ID: 25785245
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effect of TRC105 and decitabine combination in AML xenografts.
Baik J; Felices M; Yingst A; Theuer CP; Verneris MR; Miller JS; Perlingeiro R
Heliyon; 2020 Oct; 6(10):e05242. PubMed ID: 33088975
[TBL] [Abstract][Full Text] [Related]
28. Immunodeficient mouse models of lymphoid tumors.
Imada K
Int J Hematol; 2003 May; 77(4):336-41. PubMed ID: 12774920
[TBL] [Abstract][Full Text] [Related]
29. New animal models for human autoimmune thyroid disease. Xenografts of human thyroid tissue in severe combined immunodeficient (SCID) and nude mice.
Volpé R; Akasu F; Morita T; Yoshikawa N; Resetkova E; Arreaza G; Mukuta T
Horm Metab Res; 1993 Dec; 25(12):623-7. PubMed ID: 8119666
[TBL] [Abstract][Full Text] [Related]
30. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review.
Jin K; Teng L; Shen Y; He K; Xu Z; Li G
Clin Transl Oncol; 2010 Jul; 12(7):473-80. PubMed ID: 20615824
[TBL] [Abstract][Full Text] [Related]
31. An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis.
Jung N; Dai B; Gentles AJ; Majeti R; Feinberg AP
Nat Commun; 2015 Oct; 6():8489. PubMed ID: 26444494
[TBL] [Abstract][Full Text] [Related]
32. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice.
Kawai K; Resetkova E; Enomoto T; Fornasier V; Volpé R
J Clin Endocrinol Metab; 1998 Jan; 83(1):157-64. PubMed ID: 9435434
[TBL] [Abstract][Full Text] [Related]
33. Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia.
Zhang CC; Yan Z; Pascual B; Jackson-Fisher A; Huang DS; Zong Q; Elliott M; Fan C; Huser N; Lee J; Sung M; Sapra P
Neoplasia; 2018 Jan; 20(1):1-11. PubMed ID: 29172076
[TBL] [Abstract][Full Text] [Related]
34. An Experimental and Computational Protocol to Study Cell Proliferation in Human Acute Myeloid Leukemia Xenografts.
Vlachou T; Nobile MS; Ronchini C; Besozzi D; Pelicci PG
Methods Mol Biol; 2021; 2185():241-258. PubMed ID: 33165852
[TBL] [Abstract][Full Text] [Related]
35. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.
Paczulla AM; Rothfelder K; Raffel S; Konantz M; Steinbacher J; Wang H; Tandler C; Mbarga M; Schaefer T; Falcone M; Nievergall E; Dörfel D; Hanns P; Passweg JR; Lutz C; Schwaller J; Zeiser R; Blazar BR; Caligiuri MA; Dirnhofer S; Lundberg P; Kanz L; Quintanilla-Martinez L; Steinle A; Trumpp A; Salih HR; Lengerke C
Nature; 2019 Aug; 572(7768):254-259. PubMed ID: 31316209
[TBL] [Abstract][Full Text] [Related]
36. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy.
Dong X; Guan J; English JC; Flint J; Yee J; Evans K; Murray N; Macaulay C; Ng RT; Gout PW; Lam WL; Laskin J; Ling V; Lam S; Wang Y
Clin Cancer Res; 2010 Mar; 16(5):1442-51. PubMed ID: 20179238
[TBL] [Abstract][Full Text] [Related]
37. Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research.
Landuzzi L; Ruzzi F; Lollini PL; Scotlandi K
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765545
[TBL] [Abstract][Full Text] [Related]
38. Patient-derived tumor xenografts: transforming clinical samples into mouse models.
Siolas D; Hannon GJ
Cancer Res; 2013 Sep; 73(17):5315-9. PubMed ID: 23733750
[TBL] [Abstract][Full Text] [Related]
39. Modeling Spontaneous Bone Metastasis Formation of Solid Human Tumor Xenografts in Mice.
Labitzky V; Baranowsky A; Maar H; Hanika S; Starzonek S; Ahlers AK; Stübke K; Koziolek EJ; Heine M; Schäfer P; Windhorst S; Jücker M; Riecken K; Amling M; Schinke T; Schumacher U; Valentiner U; Lange T
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32046143
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
